Literature DB >> 23650309

Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure.

Takeshi Aiba1, Andreas S Barth, Geoffrey G Hesketh, Yasmin L Hashambhoy, Khalid Chakir, Richard S Tunin, Joseph L Greenstein, Raimond L Winslow, David A Kass, Gordon F Tomaselli.   

Abstract

BACKGROUND: Slowed Na⁺ current (INa) decay and enhanced late INa (INa-L) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na⁺ channel gating in CRT remains unexplored. METHODS AND
RESULTS: Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). INa and INa-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of INa availability by -3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased INa-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced INa-L, abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca²⁺/Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na⁺ channels. In a canine AP model, alterations of INa-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes.
CONCLUSIONS: CRT improves DHF-induced alterations of Na⁺ channel function, especially suppression of INa-L, thus, abbreviating the APD and reducing the frequency of early afterdepolarizations. Changes in the levels of phosphorylated Ca²⁺/Calmodulin protein kinase II suggest a molecular pathway for regulation of INa by biventricular pacing of the failing heart.

Entities:  

Keywords:  Na+ channels; arrhythmias; cardiac resynchronization therapy; electrophysiology; heart failure

Mesh:

Substances:

Year:  2013        PMID: 23650309      PMCID: PMC4114055          DOI: 10.1161/CIRCEP.113.000400

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  44 in total

Review 1.  Electrophysiological remodeling in hypertrophy and heart failure.

Authors:  G F Tomaselli; E Marbán
Journal:  Cardiovasc Res       Date:  1999-05       Impact factor: 10.787

2.  Intracellular Na(+) concentration is elevated in heart failure but Na/K pump function is unchanged.

Authors:  Sanda Despa; Mohammed A Islam; Christopher R Weber; Steven M Pogwizd; Donald M Bers
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

3.  Reactive oxygen species-activated Ca/calmodulin kinase IIδ is required for late I(Na) augmentation leading to cellular Na and Ca overload.

Authors:  Stefan Wagner; Hanna M Ruff; Sarah L Weber; Sarah Bellmann; Thomas Sowa; Timo Schulte; Mark E Anderson; Eleonora Grandi; Donald M Bers; Johannes Backs; Luiz Belardinelli; Lars S Maier
Journal:  Circ Res       Date:  2011-01-20       Impact factor: 17.367

4.  Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes.

Authors:  T Kiyosue; M Arita
Journal:  Circ Res       Date:  1989-02       Impact factor: 17.367

5.  Down-regulation of sodium current in chronic heart failure: effect of long-term therapy with carvedilol.

Authors:  V A Maltsev; H N Sabbab; A I Undrovinas
Journal:  Cell Mol Life Sci       Date:  2002-09       Impact factor: 9.261

6.  Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block.

Authors:  Christophe Leclercq; Owen Faris; Richard Tunin; Jennifer Johnson; Ritsuchi Kato; Frank Evans; Julio Spinelli; Henry Halperin; Elliot McVeigh; David A Kass
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

7.  Regional alterations in protein expression in the dyssynchronous failing heart.

Authors:  David D Spragg; Christophe Leclercq; Morteza Loghmani; Owen P Faris; Richard S Tunin; Deborah DiSilvestre; Elliot R McVeigh; Gordon F Tomaselli; David A Kass
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

8.  Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties.

Authors:  Charles Antzelevitch; Luiz Belardinelli; Andrew C Zygmunt; Alexander Burashnikov; José M Di Diego; Jeffrey M Fish; Jonathan M Cordeiro; George Thomas
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

9.  Na(+)-Ca(2+) exchanger overexpression predisposes to reactive oxygen species-induced injury.

Authors:  Stefan Wagner; Tim Seidler; Eckard Picht; Lars S Maier; Victor Kazanski; Nils Teucher; Wolfgang Schillinger; Burkert Pieske; Gerrit Isenberg; Gerd Hasenfuss; Harald Kögler
Journal:  Cardiovasc Res       Date:  2003-11-01       Impact factor: 10.787

10.  Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome.

Authors:  Lin Wu; John C Shryock; Yejia Song; Yuan Li; Charles Antzelevitch; Luiz Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  2004-03-18       Impact factor: 4.030

View more
  11 in total

Review 1.  Electrical remodeling in dyssynchrony and resynchronization.

Authors:  Takeshi Aiba; Gordon Tomaselli
Journal:  J Cardiovasc Transl Res       Date:  2012-01-21       Impact factor: 4.132

2.  Cardiac resynchronization therapy reduces expression of inflammation-promoting genes related to interleukin-1β in heart failure.

Authors:  Kenneth Bilchick; Hema Kothari; Aditya Narayan; James Garmey; Abdullah Omar; Brian Capaldo; Coleen McNamara
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

Review 3.  Animal Models to Study Cardiac Arrhythmias.

Authors:  Daniel J Blackwell; Jeffrey Schmeckpeper; Bjorn C Knollmann
Journal:  Circ Res       Date:  2022-06-09       Impact factor: 23.213

Review 4.  Cellular and Molecular Aspects of Dyssynchrony and Resynchronization.

Authors:  Jonathan A Kirk; David A Kass
Journal:  Card Electrophysiol Clin       Date:  2015-12

5.  Myocyte repolarization modulates myocardial function in aging dogs.

Authors:  Andrea Sorrentino; Sergio Signore; Khaled Qanud; Giulia Borghetti; Marianna Meo; Antonio Cannata; Yu Zhou; Ewa Wybieralska; Marco Luciani; Ramaswamy Kannappan; Eric Zhang; Alex Matsuda; Andrew Webster; Maria Cimini; Elizabeth Kertowidjojo; David A D'Alessandro; Oriyanhan Wunimenghe; Robert E Michler; Christopher Royer; Polina Goichberg; Annarosa Leri; Edward G Barrett; Piero Anversa; Thomas H Hintze; Marcello Rota
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

6.  C-terminal phosphorylation of NaV1.5 impairs FGF13-dependent regulation of channel inactivation.

Authors:  Sophie Burel; Fabien C Coyan; Maxime Lorenzini; Matthew R Meyer; Cheryl F Lichti; Joan H Brown; Gildas Loussouarn; Flavien Charpentier; Jeanne M Nerbonne; R Reid Townsend; Lars S Maier; Céline Marionneau
Journal:  J Biol Chem       Date:  2017-09-07       Impact factor: 5.157

7.  Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders.

Authors:  Vassilios J Bezzerides; Aifeng Zhang; Ling Xiao; Bridget Simonson; Santosh A Khedkar; Shiro Baba; Filomena Ottaviano; Stacey Lynch; Katherine Hessler; Alan C Rigby; David Milan; Saumya Das; Anthony Rosenzweig
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

8.  The mechanical effects of CRT promoting autophagy via mitochondrial calcium uniporter down-regulation and mitochondrial dynamics alteration.

Authors:  Ziqing Yu; Xue Gong; Yong Yu; Minghui Li; Yixiu Liang; Shengmei Qin; Zibire Fulati; Nianwei Zhou; Xianhong Shu; Zhenning Nie; Shimo Dai; Xueying Chen; Jingfeng Wang; Ruizhen Chen; Yangang Su; Junbo Ge
Journal:  J Cell Mol Med       Date:  2019-04-02       Impact factor: 5.310

9.  Rationale and design of the IRON-CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy.

Authors:  Pieter Martens; Matthias Dupont; Jeroen Dauw; Frauke Somers; Lieven Herbots; Philippe Timmermans; Jan Verwerft; Wilfried Mullens
Journal:  ESC Heart Fail       Date:  2019-09-28

Review 10.  Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia.

Authors:  Kevin P Vincent; Andrew D McCulloch; Andrew G Edwards
Journal:  Front Pharmacol       Date:  2014-05-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.